Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 20, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Erin Wright Maintained (XRAY) at Buy with Decreased Target to $43 on, Oct 20th, 2023
Erin Wright of Morgan Stanley, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Buy with Decreased Target from $47 to $43 on, Oct 20th, 2023.
Erin has made no other calls on XRAY in the last 4 months.
There are 2 other peers that have a rating on XRAY. Out of the 2 peers that are also analyzing XRAY, 1 agrees with Erin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jason Bednar of "Piper Sandler" Maintained at Hold with Decreased Target to $39 on, Friday, September 22nd, 2023
This is the rating of the analyst that currently disagrees with Erin
- Michael Petusky of "Barrington Research" Reiterated at Buy and Held Target at $51 on, Friday, August 4th, 2023
